15.8 C
Delhi
Tuesday, December 1, 2020

Biocon to launch drug for COVID-19 patients; priced at Rs 8,000 per vial

- Advertisement -

Biocon to launch drug for COVID-19 patients; priced at Rs 8,000 per vialNew Delhi, Jul 13 (PTI) Biotechnology major Biocon on Monday said it will launch biologic drug Itolizumab for the treatment of moderate to severe COVID-19 patients at a price of around 8,000 per vial.

The company has received approval from the  Drugs Controller General of India (DCGI) to market Itolizumab injection 25mg/5mL solution for emergency use in India for the treatment of cytokine release syndrome in moderate to severe acute respiratory distress syndrome (ARDS) due to COVID-19.

Itolizumab is the first novel biologic therapy to be approved anywhere in the world for treating patients with moderate to severe COVID-19 complications, Biocon had earlier said in a regulatory filing.

“Until the vaccine comes, we certainly need life saving drugs. I think what we are doing across the world is to see how we can either repurpose drugs or develop new drugs to treat this pandemic,” Biocon Executive Chairperson Kiran Mazumdar-Shaw said in a virtual press conference.

READ ALSO:  AgustaWestland: Michel bought tickets worth Rs 92 lakh for 2 IAF officers, says CBI

Even if we get a vaccine by the end of this year or early next year, there is no guarantee that there will not be reinfection, there is no guarantee that it will work the way we expect it to work, so we must be in a state of preparedness, she added.

“When COVID happened, we said it actually gives us a very strong case to try it (Itolizumab) for COVID, because we do believe that the unique mechanism of action that it has can help us deal with this storm that we have seen is killing patients,”” Mazumdar-Shaw said.

Itolizumab is approved for moderate to severe acute respiratory distress syndrome (ARDS) due to COVID-19, she added.

The cost of per vial is Rs 7,950. As most patients need 4 vials, the cost of the therapy is around Rs 32,000, Mazumdar-Shaw said.

READ ALSO:  For COVID-19 patients with diabetes, blood sugar control is key

On being asked if the company is ramping up the capacity to manufacture more vials on account of the pandemic, she said: “We have the manufacturing capacity and the supply and distribution network in place, however post this approval we are looking to ramp up production capacity to meet the expected surge in demand. Our aim is to reach a larger number of patients across the country”.

The drug will be manufactured and formulated as an intravenous injection at the company”s bio-manufacturing facility at Biocon Park, Bengaluru.

When asked about the steps the company is taking to ensure availability of the drug, Mazumdar-Shaw said: “Alzumab is already in market, we will be supplying to hospitals as per protocol against a medical prescription and patient consent form. Currently, there is a huge demand and Biocon wants to ensure Itolizumab first reaches those patients who need them the most”. PTI AKT BAL

India Updates
India Updates is an independent news & Information website. Follow us for regular updates on News and Information.

Follow Us On

Related News

Hansal Mehta decodes why sports-based films do well

New Delhi, Nov 30 (IANS) Filmmaker Hansal Mehta, who is currently riding high on the success of his new sports drama Chhalaang, has revealed...

Italian watchdog fines Apple 10mn euros over waterproofing claims

London, Nov 30 (IANS) The Italian anti-trust watchdog on Monday slapped a fine of 10 million euros on Apple for unfair commercial practices related...

Festive push: Auto stocks to be in focus on Tuesday’s trade

Mumbai, Nov 30 (IANS) As the country's stock markets recommence trade on Tuesday after an extended weekend, analysts believe that automobile, manufacturing and utilities...

Malaria cases in India drops to 5.6mn in 2019: WHO report

New Delhi, Nov 30 (IANS) Malaria cases in India dropped from about 20 million cases in 2000 to about 5.6 million in 2019, said...

Babuji left me his life and works, says Amitabh Bachchan

Mumbai, Nov 30 (IANS): Iconic actor Amitabh Bachchan says his life and work is nothing compared to the legacy of his father and late eminent...

India’s 5G subscription to surpass 350 mn in 2026: Ericsson

New Delhi, Nov 30 (IANS) In India, 5G subscriptions will surpass 350 million, accounting for 27 per cent of all mobile subscriptions in 2026,...

Trending Topics In India

Covid 19 India Updates

Moderna asking US, European regulators to greenlight Covid-19 vax

By Nikhila Natarajan, (IANS): Moderna Inc, which has reported its Covid-19 vaccine is 94 per cent effective, on Monday announced it is filing with US...

Moderna asking US, European regulators to greenlight Covid-19 vax

By Nikhila Natarajan, (IANS): Moderna Inc, which has reported its Covid-19 vaccine is 94 per cent effective, on Monday announced it is filing with US...

Kerala, Maha, Delhi among 6 states with 61% new Covid cases detected every day

By Rajnish Singh, (IANS) Kerala, Maharashtra and Delhi are among top six states which are accountable for contributing 61 per cent new Covid-19 cases on daily basis in India,...

Looking at vaccine manufacture, delivery ecosystem: Harsh Vardhan

New Delhi, Nov 25 (IANS) At a time the world is racing against time to find a safe and effective vaccine against Covid-19, Union...

Apollo Hospitals gearing up to give one million vaccines a day

New Delhi, Nov 25 (IANS) Apollo Hospitals are gearing up to give one million vaccines a day once it is available across India through...

Over 88% Indians know at least one Covid infected person: Survey

New Delhi, Nov 25 (IANS) With over nine million coronavirus cases in India, 88 per cent citizens now have one or more contacts in...

Trending News In India

This year entertainment was a larger source of escape, says Namit Das

Mumbai, Nov 28 (IANS) The year 2020 has been a gloomy one due to the pandemic, and actor Namit Das feels that entertainment turned...

Italian watchdog fines Apple 10mn euros over waterproofing claims

London, Nov 30 (IANS) The Italian anti-trust watchdog on Monday slapped a fine of 10 million euros on Apple for unfair commercial practices related...

Festive push: Auto stocks to be in focus on Tuesday’s trade

Mumbai, Nov 30 (IANS) As the country's stock markets recommence trade on Tuesday after an extended weekend, analysts believe that automobile, manufacturing and utilities...

World Test Championship format needs a review: ICC chief

By Qaiser Mohammad Ali,  (IANS) Four days after India captain Virat Kohli described the new percentage points system of the much-debated World Test Championship...

Malaria cases in India drops to 5.6mn in 2019: WHO report

New Delhi, Nov 30 (IANS) Malaria cases in India dropped from about 20 million cases in 2000 to about 5.6 million in 2019, said...

Babuji left me his life and works, says Amitabh Bachchan

Mumbai, Nov 30 (IANS): Iconic actor Amitabh Bachchan says his life and work is nothing compared to the legacy of his father and late eminent...

Trending Showbiz

This year entertainment was a larger source of escape, says Namit Das

Mumbai, Nov 28 (IANS) The year 2020 has been a gloomy one due to the pandemic, and actor Namit Das feels that entertainment turned...

Babuji left me his life and works, says Amitabh Bachchan

Mumbai, Nov 30 (IANS): Iconic actor Amitabh Bachchan says his life and work is nothing compared to the legacy of his father and late eminent...

This year entertainment was a larger source of escape, says Namit Das

Mumbai, Nov 28 (IANS) The year 2020 has been a gloomy one due to the pandemic, and actor Namit Das feels that entertainment turned...

Comedy teaches you to live in the moment: Saqib Saleem

Actor Saqib Saleem, who has done roles across genres in films, feels comedy is the genre that teaches an actor to live in the...

Indian Award shows should include films released on OTT: Bhumi

Mumbai, Nov 27 (IANS) Actress Bhumi Pednekar is not new to the web space, her film Dolly Kitty Aur Woh Chamakte Sitare dropped on...

Sanjay Dutt’s new film ‘Torbaaz’ discusses terrorism with human angle

Mumbai, Nov 26 (IANS) Filmmaker Girish Malik, who directs Sanjay Dutt in his new film Torbaaz, says he wanted to show a story of...

Trending Sports

Playing with crowds after long may have affected catching: Rahul

Sydney, Nov 29 (IANS) India's fielding woes continued in the second One-Day International against Australia at the Sydney Cricket Ground (SCG) on Sunday with...

India fall to 51-run defeat; Australia win series

Sydney, Nov 29 (IANS): Australia beat India by 51 runs in the second ODI on Sunday at the Sydney Cricket Ground (SCG). The hosts have...

Australia will win series in all formats vs India: predicts Vaughan

New Delhi, Nov 28 (IANS) Hosts Australia are the favourites to win the series against India across all formats, former England captain Michael Vaughan has...

Premier Badminton League season 6 postponed due to Covid-19

New Delhi, Nov 27 (IANS) The sixth season of the Premier Badminton League (PBL), which was scheduled to take place in late December, has...

Kohli hits out at team for not getting into ODI mode from T20

New Delhi, Nov 27 (IANS) India skipper Virat Kohli hit out at his team for not getting into 50-over format rhythm for the ongoing three-match...

Latest Trending News In India

Italian watchdog fines Apple 10mn euros over waterproofing claims

London, Nov 30 (IANS) The Italian anti-trust watchdog on Monday slapped a fine of 10 million euros on Apple for unfair commercial practices related...

Festive push: Auto stocks to be in focus on Tuesday’s trade

Mumbai, Nov 30 (IANS) As the country's stock markets recommence trade on Tuesday after an extended weekend, analysts believe that automobile, manufacturing and utilities...

World Test Championship format needs a review: ICC chief

By Qaiser Mohammad Ali,  (IANS) Four days after India captain Virat Kohli described the new percentage points system of the much-debated World Test Championship...

Malaria cases in India drops to 5.6mn in 2019: WHO report

New Delhi, Nov 30 (IANS) Malaria cases in India dropped from about 20 million cases in 2000 to about 5.6 million in 2019, said...